Received Apr 14, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | AMXB064A | — |
Menveo -Administration after expiration date; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 19-year-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number AMAB064A, expiry date 31-DEC-2025) and (batch number AMXB064A, expiry date 31-DEC-2025) for prophylaxis. On 07-APR-2026, the patient received Menveo. On 07-APR-2026, an unknown time after receiving Menveo, the patient experienced expired vaccine used (Verbatim: Menveo -Administration after expiration date). The outcome of the expired vaccine used was not applicable. Additional Information: GSK receipt date: 07-APR-2026 A medical assistant reported that the patient received an expired Menveo (2 vial) vaccine dose.